Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its ...

The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement ...

A former FDA commissioner and a former Institute of Medicine president are teaming up to create the Vaccine Integrity Project ...

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

The World Vaccine Congress kicks off its annual conference this week in Washington, bringing together researchers, pharma ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, public health organizations, state health officials, vaccine manufacturers, ...

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by “gold standard ...